ClinicalTrials.gg
Not yet recruitingNCT07869316Updated Oct 16, 2026

Subcostal TAP Block Versus Combined Subcostal TAP and Recto-Intercostal Fascial Plane Block for Analgesia After Laparoscopic Cholecystectomy

An interventional study of Subcostal Transversus Abdominis Plane Block and Recto-Intercostal Fascial Plane Block in Laparoscopic Cholecystectomy and Postoperative Pain, sponsored by Diskapi Yildirim Beyazit Education and Research Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Diskapi Yildirim Beyazit Education and Research Hospital · Not applicable, Interventional, and Treatment

Updated Oct 16, 2026Eligibility revisedPrimary outcomes revised+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Laparoscopic cholecystectomy is commonly associated with moderate postoperative pain, particularly during the early postoperative period. Inadequate postoperative analgesia may negatively affect patient comfort and recovery, increase opioid consumption, and contribute to opioid-related adverse effects. Therefore, effective multimodal analgesic strategies are of considerable importance in patients undergoing laparoscopic cholecystectomy.

Subcostal transversus abdominis plane (TAP) block is a regional anesthesia technique used to provide analgesia for upper abdominal surgery. However, its analgesic coverage may be insufficient in some patients because of the complex innervation of the upper abdominal wall. The recto-intercostal fascial plane block has been described as a fascial plane block targeting the anterior branches of the thoracoabdominal nerves and may provide additional analgesic benefit when combined with subcostal TAP block.

This study aims to compare the postoperative analgesic efficacy of bilateral subcostal TAP block alone with that of bilateral subcostal TAP block combined with recto-intercostal fascial plane block in patients undergoing elective laparoscopic cholecystectomy.

02

Conditions studied

  • Laparoscopic Cholecystectomy
  • Postoperative Pain

Browse trials for

Keywords

  • Laparoscopic cholecystectomy
  • Transversus abdominis plane block
  • Recto-intercostal fascial plane block
03

In context

Pain, Postoperative

5,224 studies on the registry are indexed under Pain, Postoperative; 1,154 are open to participants now.

This study's planned enrollment of 90 is above the median of 75 across 4,457 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Diskapi Yildirim Beyazit Education and Research Hospital is the lead sponsor of 70 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 80 years
  • With a body mass index (BMI) between 18 and 30 kg/m².
  • American Society of Anesthesiologists (ASA) physical status I, II, or III
  • Scheduled to undergo elective laparoscopic cholecystectomy

Exclusion criteria

Exclusion Criteria:

  • Age younger than 18 years or older than 80 years
  • With a body mass index (BMI) below 18 or above 30 kg/m²
  • American Society of Anesthesiologists (ASA) physical status IV or higher
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Active comparator
    Subcostal Transversus Abdominis Plane Block

    Following induction of general anesthesia and before surgical incision, participants will receive a bilateral ultrasound-guided subcostal transversus abdominis plane block using a total volume of 40 mL of 0.20% bupivacaine.

    Procedure: Subcostal Transversus Abdominis Plane Block

  • Active comparator
    Subcostal Transversus Abdominis Plane Block + Recto-Intercostal Fascial Plane Block

    Following induction of general anesthesia and before surgical incision, participants will receive a bilateral ultrasound-guided subcostal transversus abdominis plane block using a total volume of 40 mL of 0.20% bupivacaine together with a bilateral ultrasound-guided recto-intercostal fascial plane block using a total volume of 30 mL of 0.20% bupivacaine.

    Procedure: Subcostal Transversus Abdominis Plane Block · Procedure: Recto-Intercostal Fascial Plane Block

Interventions

  • ProcedureSubcostal Transversus Abdominis Plane Block

    Following induction of general anesthesia and before surgical incision, a bilateral ultrasound-guided subcostal transversus abdominis plane block will be performed using a total volume of 40 mL of 0.20% bupivacaine.

  • ProcedureRecto-Intercostal Fascial Plane Block

    Following induction of general anesthesia and before surgical incision, a bilateral ultrasound-guided recto-intercostal fascial plane block will be performed using a total volume of 30 mL of 0.20% bupivacaine.

06

What researchers measure

Primary outcomes

  1. Pain Score

    Pain will be assessed at rest using the visual analog scale on a scale from 0 (no pain) to 100 (worst pain). Pain assessment will be done at 6th hour after surgery.

    Time frame: At 6 hours after surgery.

Secondary outcomes

  1. Pain Scores

    Pain will be assessed at rest using the visual analog scale on a scale from 0 (no pain) to 100 (worst pain). Pain assessment will be done at 0st, 1st, 2nd, 12th, and 24th hours after surgery.

    Time frame: At 0, 1, 2, 12, and 24 hours after surgery.

  2. Total Postoperative Opioid Consumption During the First 24 Hours After Surgery

    Total Postoperative Opioid Consumption During the First 24 Hours After Surgery

    Time frame: During the first 24 hours after surgery.

07

Study locations

1 site
08

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Oct 2027, 12 months later.

Of 1,888 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 12 months is close to that.

Counting every sponsor, half of 1,901 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2026
First posted
Oct 9, 2026
StartEst.
Oct 14, 2026
Primary completionEst.
Oct 15, 2027
CompletionEst.
Oct 29, 2027
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Also revised
eligibility, primary outcomes and interventions
Registered
First appeared on the registry
Oct 9, 2026
Show all 2 updates
  1. Oct 16, 2026
    Eligibility Criteria revised
    Primary outcomes Revised (1 change)
    Interventions Arms or interventions changed
    + 1 other change: secondary outcomes
  2. Oct 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07869316
Lead sponsor
Diskapi Yildirim Beyazit Education and Research Hospital
Responsible party
Elif Sule Ozdemir (Principal Investigator, Ankara Etlik City Hospital) — Principal investigator
First posted
Oct 9, 2026
Start date
Oct 14, 2026 (estimated)
Primary completion
Oct 15, 2027 (estimated)
Completion
Oct 29, 2027 (estimated)
Last update
Oct 16, 2026

Study contacts

Elif Şule Özdemir Sezgi
Contact
elifsule-91@hotmail.com
00905059209638
Aslı Dönmez
Contact
aslidonmez@hotmail.com
00905322256473

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion